Gastrointestinal Stromal Tumor: New Insights for a Multimodal Approach
- PMID: 35715143
- PMCID: PMC10185044
- DOI: 10.1016/j.soc.2022.03.007
Gastrointestinal Stromal Tumor: New Insights for a Multimodal Approach
Abstract
Over the past 20 years, gastrointestinal stromal tumor (GIST) has evolved into an increasingly complex clinical entity with ever more challenges. While surgical resection is the gold standard, advancements in genetic testing, therapeutic options, immunotherapy, and management of metastatic disease necessitate a comprehensive, multimodal approach for these tumors. This chapter highlights the importance of genomic testing of GIST, the use of neoadjuvant and adjuvant therapy for localized disease, surgical principles for GIST, as well as current and new approaches for addressing metastatic disease.
Keywords: Gastrointestinal Stromal Tumor; Immunotherapy; Next Generation Sequencing; Tyrosine Kinase Inhibitors.
Copyright © 2022 Elsevier Inc. All rights reserved.
References
-
- Coe TM, Sicklick JK. Epidemiology of GIST. In: Scoggins CR, Raut CP, Mullen JT, editors. Gastrointestinal stromal tumors: bench to bedside. Cham: Springer International Publishing; 2017. p. 7–15.
-
- Roland CL, Feig BW. History of GIST. In: Scoggins CR, Raut CP, Mullen JT, editors. Gastrointestinal stromal tumors: bench to bedside. Cham: Springer International Publishing; 2017. p. 1–5.
-
- Hirota S, Isozaki K, Moriyama Y, et al. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science 1998;279(5350):577–80. - PubMed
-
- Heinrich MC, Corless CL, Duensing A, et al. PDGFRA activating mutations in gastrointestinal stromal tumors. Science 2003;299(5607):708–10. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous
